🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate t...
Status
Recruiting
Location
UZ Leuven
Start Date
2026-08
Trial ID
NCT07587242
This Phase 2 study (EPIMODE) will evaluate the efficacy and safety of CS1 c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-15
Trial ID
NCT07761572
The investigators developed a dual-target CAR-T targeting CD38 and CS1. Pre...
Status
Active Not Recruiting
Location
Second Hospital of Shandong University
Start Date
2024-04-30
Trial ID
NCT06574958
Treatments Being Tested
This is a single-center, open-label, single-arm study to evaluate the safet...
Status
Unknown
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2020-03-25
Trial ID
NCT04662099
Treatments Being Tested
This trial is conducted to evaluate the safety and technical effectiveness ...
Status
Completed
Location
Kobe City General Hospital
Start Date
2016-05
Trial ID
NCT02907229
Treatments Being Tested
CS1-004 will be an extension of the CS1-003 Study. The primary objective of...
Status
No Longer Available
Location
Fredrik Frick
Start Date
TBD
Trial ID
NCT06321705
Treatments Being Tested
SAD study: Eighteen subjects will be included in the SAD study (single dos...
Status
Completed
Location
CTC Clinical Trial Consultants AB
Start Date
2017-10-06
Trial ID
NCT03903302
Treatments Being Tested
Explore the impact of drug candidate CS1 on pathological vascular remodelin...
Status
Completed
Location
Prisma Health
Start Date
2025-03-14
Trial ID
NCT06907693
Treatments Being Tested
This phase I trial studies the side effects and best dose of CS1-chimeric a...
Status
Suspended
Location
City of Hope Medical Center
Start Date
2019-04-23
Trial ID
NCT03710421
Treatments Being Tested
The purpose of this Managed Access Program is to allow access to delpacibar...
Status
Available
Location
University of Alabama
Start Date
TBD
Trial ID
NCT07250737
Treatments Being Tested